Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Diaz-Arevalo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2017
CD4<sup>+</sup> T Cells Mediate Aspergillosis Vaccine ProtectionDiana Diaz-Arevalo, Markus Kalkum
Frontiers in Microbiology|October 2, 2012
Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis VaccineDiana Diaz-Arevalo, James I Ito, Markus Kalkum
Infection and Immunity|March 23, 2011
CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccineDiana Diaz-Arevalo, Karine Bagramyan, Teresa B Hong, et al.
Comparative Medicine|December 12, 2013
Hypothermic endpoint for an intranasal invasive pulmonary aspergillosis mouse modelTrinka W Adamson, Diana Diaz-Arevalo, Tracey M Gonzalez, et al.
Medical Mycology|February 28, 2009
Vaccine progressJames I Ito, Joseph M Lyons, Diana Diaz-Arevalo, et al.
Annals of the New York Academy of Sciences|December 13, 2012
Protein targets for broad-spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogensJackson Champer, Diana Diaz-Arevalo, Miriam Champer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2017
CD4<sup>+</sup> T Cells Mediate Aspergillosis Vaccine ProtectionDiana Diaz-Arevalo, Markus Kalkum
Frontiers in Microbiology|October 2, 2012
Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis VaccineDiana Diaz-Arevalo, James I Ito, Markus Kalkum
Infection and Immunity|March 23, 2011
CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccineDiana Diaz-Arevalo, Karine Bagramyan, Teresa B Hong, et al.
Comparative Medicine|December 12, 2013
Hypothermic endpoint for an intranasal invasive pulmonary aspergillosis mouse modelTrinka W Adamson, Diana Diaz-Arevalo, Tracey M Gonzalez, et al.
Medical Mycology|February 28, 2009
Vaccine progressJames I Ito, Joseph M Lyons, Diana Diaz-Arevalo, et al.
Annals of the New York Academy of Sciences|December 13, 2012
Protein targets for broad-spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogensJackson Champer, Diana Diaz-Arevalo, Miriam Champer, et al.
Pageof 1